New drugs move through a series of clinical trial phases. Each phase answers different questions before a treatment can be approved and widely used.
| Phase | Main purpose | Typical participants |
|---|---|---|
| Phase 0 | Exploratory: how a very small dose behaves in the body | About 10 to 15 people |
| Phase I | Safety and dosage | About 20 to 100 people, often healthy volunteers |
| Phase II | Effectiveness and side effects | Up to several hundred people with the condition |
| Phase III | Confirm benefit and monitor adverse reactions, often against standard treatment | About 300 to 3,000 people |
| Phase IV | Long-term safety after approval | Large numbers of patients in routine use |
Protecting participants
- Informed consent: participants learn the risks and benefits and agree in writing before joining.
- Ethics review: an Institutional Review Board (IRB) approves and monitors each study.
- Good Clinical Practice (GCP): the international standard for designing, running and reporting trials.
Roles you’ll hear about
- Clinical Research Coordinator (CRC): runs the study day to day at a site.
- Clinical Research Associate (CRA): monitors sites for the sponsor.
- Clinical Data Manager: keeps trial data accurate and complete.